Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
150 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| S2B.WA | Syn2bio S.A. | Diagnostics | $149.26M | 64.90 PLN | −32.82% | −5.94% |
| 0ELV.L | Guerbet SA | Diagnostics | $146.82M | 7.88 EUR | −64.26% | −0.63% |
| IMDX | Insight Molecular Diagnostics Inc. | Diagnostics | $145.30M | $4.44 | −47.83% | −5.53% |
| EKF.L | EKF Diagnostics Holdings plc | Diagnostics |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| $144.58M |
| 25.40 GBP |
| −20.63% |
| −3.42% |
| BVXP.L | Bioventix PLC | Diagnostics | $124.78M | 1,750.00 GBP | −31.37% | +15.89% |
| PCSC | Perceptive Capital Solutions Corp | Diagnostics | $123.25M | $11.95 | −17.42% | +0.67% |
| SCP.WA | Scope Fluidics S.A. | Diagnostics | $120.56M | 139.80 PLN | −23.27% | +19.28% |
| S84.F | Scope Fluidics S.A. | Diagnostics | $119.81M | 27.75 EUR | −27.45% | +19.87% |
| QUCY | Quantum Cyber N.V. | Diagnostics | $110.13M | $1.36 | −72.41% | +23.64% |
| BNR | Burning Rock Biotech Limited | Diagnostics | $108.84M | $9.80 | −76.51% | +4.26% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | Diagnostics | $106.02M | 59.60 SEK | −62.66% | −12.61% |
| BIOPOR.CO | BioPorto A/S | Diagnostics | $95.88M | 1.20 DKK | −19.35% | −0.41% |
| BB1.AX | BLINKLAB FPO [BB1] | Diagnostics | $93.89M | 0.86 AUD | −22.62% | +29.55% |
| 7V0.DE | Novogenia AG | Diagnostics | $89.68M | 6.10 EUR | −48.74% | −0.81% |
| 6678.T | Techno Medica Co., Ltd. | Diagnostics | $88.56M | 2,082.00 JPY | −25.30% | +2.76% |
| AALR3.SA | Alliança Saúde e Participações S.A. | Diagnostics | $87.29M | 2.95 BRL | −56.74% | −8.39% |
| SERA | Sera Prognostics, Inc. | Diagnostics | $86.00M | $2.18 | −44.81% | +6.34% |
| MDXH | MDxHealth SA | Diagnostics | $70.73M | $0.79 | −84.16% | +88.71% |
| LDX.AX | Lumos Diagnostics Holdings Limited | Diagnostics | $67.70M | 0.11 AUD | −68.18% | +5.00% |
| KVAC | Keen Vision Acquisition Corp | Diagnostics | $63.38M | $12.01 | −35.84% | −6.17% |
| DXR | Daxor Corporation | Diagnostics | $58.38M | $10.00 | −32.25% | −2.06% |
| PRPO | Precipio, Inc. | Diagnostics | $55.23M | $30.85 | −8.27% | +34.60% |
| ALKLH.PA | KLEA HOLDING | Diagnostics | $54.68M | 0.16 EUR | −49.59% | −1.90% |
| RIBB | Ribbon Acquisition Corp. | Diagnostics | $54.52M | $10.88 | −1.05% | +0.51% |
| CYC.AX | Cyclopharm Limited | Diagnostics | $46.85M | 0.53 AUD | −59.30% | +0.96% |
| BIOBV.HE | Biohit Oyj | Diagnostics | $46.16M | 2.56 EUR | −32.28% | −6.57% |
| 0DRP.L | Biohit Oyj | Diagnostics | $45.72M | 2.60 EUR | −10.03% | −5.63% |
| ABLD.PA | ABL Diagnostics Société anonyme | Diagnostics | $45.06M | 2.36 EUR | −52.80% | −1.67% |
| ALNOV.PA | Novacyt S.A. | Diagnostics | $43.09M | 0.51 EUR | −50.58% | +14.60% |
| NCYT.L | Novacyt S.A. | Diagnostics | $43.04M | 44.00 GBP | −48.84% | +20.55% |
| PAVM | PAVmed Inc. | Diagnostics | $40.78M | $5.28 | −81.45% | +1.44% |
| ABDX.L | Abingdon Health Plc | Diagnostics | $37.08M | 11.00 GBP | −15.38% | +11.68% |
| 2385.T | Soiken Holdings Inc. | Diagnostics | $36.98M | 225.00 JPY | −30.77% | +4.17% |
| NXN.AX | Nexsen Ltd | Diagnostics | $34.40M | 0.23 AUD | −33.33% | −14.81% |
| COV.AX | Cleo Diagnostics Ltd | Diagnostics | $33.34M | 0.34 AUD | −62.22% | +6.25% |
| ACARIX.ST | Acarix AB (publ) | Diagnostics | $31.56M | 0.23 SEK | −33.24% | −7.36% |
| MBX.TO | Microbix Biosystems Inc. | Diagnostics | $30.67M | 0.30 CAD | −9.09% | −3.23% |
| GDR.L | genedrive plc | Diagnostics | $28.48M | 1.38 GBP | −8.00% | +38.00% |
| NN6.DE | NanoRepro AG | Diagnostics | $27.17M | 1.85 EUR | −22.92% | −11.48% |
| MAP.AX | Microba Life Sciences Limited | Diagnostics | $27.10M | 0.06 AUD | −47.62% | +14.58% |
| ALIKO.PA | Ikonisys S.A. | Diagnostics | $26.24M | 1.46 EUR | −20.65% | −2.67% |
| RENX.L | Renalytix Plc | Diagnostics | $25.64M | 4.25 GBP | −72.58% | +60.38% |
| RHY.AX | Rhythm Biosciences Limited | Diagnostics | $24.60M | 0.10 AUD | −65.36% | +22.78% |
| 6090.T | Human Metabolome Technologies, Inc. | Diagnostics | $21.69M | 637.00 JPY | −17.38% | +7.24% |
| PIQ.AX | Proteomics International Laboratories Ltd | Diagnostics | $19.54M | 0.17 AUD | −80.81% | +6.45% |
| ALBIO.PA | Biosynex SA | Diagnostics | $19.41M | 0.92 EUR | −41.66% | −0.43% |
| CLBX.L | CelLBxHealth plc | Diagnostics | $19.39M | 1.25 GBP | −84.37% | −1.96% |
| 4241.T | atect corporation | Diagnostics | $18.11M | 652.00 JPY | −44.98% | +3.49% |
| URT.WA | Urteste S.A. | Diagnostics | $18.10M | 43.50 PLN | −39.75% | +0.93% |
| BDX.AX | BCAL Diagnostics Limited | Diagnostics | $17.70M | 0.05 AUD | −66.45% | −26.76% |
| IIQ.AX | INOVIQ Ltd | Diagnostics | $17.65M | 0.18 AUD | −69.03% | −7.89% |
| GMT.WA | Genomtec S.A. | Diagnostics | $17.04M | 3.75 PLN | −48.84% | −6.60% |
| ADVB | Advanced Biomed Inc. | Diagnostics | $15.17M | $9.18 | −62.11% | −36.07% |
| BIOVIC-B.ST | Biovica International AB (publ) | Diagnostics | $13.90M | 0.44 SEK | −35.16% | −12.60% |
| BACTIQ.CO | BactiQuant A/S | Diagnostics | $13.59M | 2.40 DKK | −40.00% | +2.56% |
| GSS.AX | Genetic Signatures Limited | Diagnostics | $13.51M | 0.08 AUD | −80.70% | +38.33% |
| TRI.AX | TrivarX Limited | Diagnostics | $13.23M | 0.02 AUD | −54.29% | −5.88% |
| BOUL.ST | Boule Diagnostics AB (publ) | Diagnostics | $13.10M | 3.21 SEK | −51.66% | −8.29% |
| CRM.WA | PZ Cormay S.A. | Diagnostics | $11.93M | 0.52 PLN | −41.57% | +5.48% |
| BMX.WA | BioMaxima S.A. | Diagnostics | $11.54M | 10.14 PLN | −30.07% | +1.60% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.